Sun et al. revealed that FGFR2 was a direct and functional downstream target of miR-889 in CC cells, and miR-889 overexpression suppressed CC viability and invasion by targeting FGFR (41), and FGFR2 has become a new target for female reproductive system cancers therapy (42). This evidence concerns the gene FGFR2 and reproductive system cancer.